LAssa Fever Adjunct Treatment With DEXamethasone
Conditions: Lassa Fever Interventions: Drug: Dexamethasone; Drug: Ribavirin Sponsors: Bernhard Nocht Institute for Tropical Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
Conditions: Lassa Fever Interventions: Drug: Favipiravir; Drug: Ribavirin; Drug: Dexamethasone Sponsors: Irrua Specialist Teaching Hospital; Alliance for International Medical Action; University of Bordeaux; Bernhard Nocht Institute for Tropical Medicine; Federal Medical Centre, Owo; Programme PAC-CI, Site ANRS-MIE de C ôte d ' Ivoire; Fondation pour la Recherche Scientifique, Benin; M édecins Sans Frontières, Belgium; Alex Ekwueme Federal University Teaching Hospital; Donka Hospital, Conakry; Centre de Recherche Médicale de Lambaréné; University of Hamburg-Eppendorf; Phebe Hospital, Liberia; University of North Caro...
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
Condition: Lassa Fever Interventions: Drug: Day 1 Lower Dose (2×106 pfu); Drug: Day 1 Higher Dose (1×107 pfu); Drug: Placebo Sponsors: International AIDS Vaccine Initiative; Coalition for Epidemic Preparedness Innovations Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials
INOVIO Provides an Update on Lassa Fever and MERS Programs
PLYMOUTH MEETING, Pa., Nov. 17, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, today... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 17, 2022 Category: Pharmaceuticals Source Type: clinical trials
Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever
Condition: Lassa Fever Interventions: Drug: Ribavirin iv; Drug: Favipiravir Sponsors: Bernhard Nocht Institute for Tropical Medicine; University of Hamburg; Alliance for International Medical Action; Institut National de la Santé Et de la Recherche Médicale, France; University of Bordeaux; Federal Medical Centre, Owo; Irrua Specialist Teachin g Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2021 Category: Research Source Type: clinical trials
